Advertisement

Pathologie pp 523-600 | Cite as

Indolente und kleinzellige B-Zell Lymphome

  • German Ott
Chapter

Zusammenfassung

In diesem Kapitel wird die große Gruppe der klein- und mittelgroßzelligen malignen Lymphome und ihre Varianten nach den Gesichtspunkten der neuen WHO Klassifikation und auf dem Boden pathogenetischer Prinzipien ihrer Entwicklung und Progression behandelt. Wichtig ist, dass zwar der diagnostische histopathologische Befund des Lymphknotenbefalls im Vordergrund steht, aber bei der üblichen systemischen Ausbreitung auf die Manifestation als leukämisches Bild und auf häufig biopsierte Manifestationsorte hingewiesen wird. Auch werden die in der Differenzialdiagnose wichtigen Formen der Marginalzonenlymphome mit lokalisiertem extranodalem Befall besprochen. Daraus entsteht ein umfassendes und durch Bilddokumente gut untermauertes Gesamtbild, aus dem die klinisch relevanten diagnostischen Strategien abgeleitet werden können.

Literatur

  1. 1.
    Adam P, Baumann R, Schmidt J, Bettio S, Weisel K, Bonzheim I, Fend F, Quintanilla-Martinez L (2013) The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-„negative“ grade 1/2 follicular lymphomas. Hum Pathol 44:1817–1826PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Adam P, Katzenberger T, Eifert M, Ott MM, Rosenwald A, Muller-Hermelink HK, Ott G (2005) Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol 29:1661–1664PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Adam P, Schiefer AI, Prill S, Henopp T, Quintanilla-Martinez L, Bosmuller HC, Chott A, Fend F (2012) Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues. Mod Pathol 25:1629–1636PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Agopian J, Navarro JM, Gac AC, Lecluse Y, Briand M, Grenot P, Gauduchon P, Ruminy P, Lebailly P, Nadel B, Roulland S (2009) Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med 206:1473–1483PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Alvaro T, Lejeune M, Salvado MT, Lopez C, Jaen J, Bosch R, Pons LE (2006) Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 24:5350–5357PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Arribas AJ, Campos-Martin Y, Gomez-Abad C, Algara P, Sanchez-Beato M, Rodriguez-Pinilla MS, Montes-Moreno S, Martinez N, ves-Ferreira J, Piris MA, Mollejo M (2012) Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets. Blood 119:e9–e21PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Attygalle AD, Liu H, Shirali S, Diss TC, Loddenkemper C, Stein H, Dogan A, Du MQ, Isaacson PG (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 104:3343–3348CrossRefPubMedGoogle Scholar
  8. 8.
    Bacon CM, Diss TC, Ye H, Liu H, Goatly A, Hamoudi R, Wotherspoon A, Gascoyne RD, Dogan A, Du MQ, Isaacson PG (2009) Follicular lymphoma of the thyroid gland. Am J Surg Pathol 33:22–34PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Bacon CM, Ye H, Diss TC, McNamara C, Kueck B, Hasserjian RP, Rohatiner AZ, Ferry J, Du MQ, Dogan A (2007) Primary follicular lymphoma of the testis and epididymis in adults. Am J Surg Pathol 31:1050–1058PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES (1992) Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637–640PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Barth TF, Barth CA, Kestler HA, Michl P, Weniger MA, Buchholz M, Moller P, Gress T (2007) Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol 211:305–313PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Baumhoer D, Tzankov A, Dirnhofer S, Tornillo L, Terracciano LM (2008) Patterns of liver infiltration in lymphoproliferative disease. Histopathology 53:81–90PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Bea S, Valdes-Mas R, Navarro A, Salaverria I, Martin-Garcia D, Jares P, Gine E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizan P, Di CL, Puente DA, Lopez-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martinez A, Valera A, Martin-Subero JI, Amador V, Hernandez L, Rozman M, Enjuanes A, Forcada P, Muntanola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernandez-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, Lopez-Guillermo A, Lopez-Otin C, Puente XS, Campo E (2013) Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A 110:18250–18255PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Bende RJ, Smit LA, Bossenbroek JG, Aarts WM, Spaargaren M, de Leval LL, Boeckxstaens GE, Pals ST, van Noesel CJ (2003) Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 162:105–113PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller-Hermelink HK, Baudis M, Barth TF, Moller P, Lichter P, Dohner H (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 27:285–294PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95:1950–1956PubMedPubMedCentralGoogle Scholar
  17. 17.
    Bob R, Falini B, Marafioti T, Paterson JC, Pileri S, Stein H (2013) Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers. Histopathology 63:482–498PubMedPubMedCentralGoogle Scholar
  18. 18.
    Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, Dave BJ, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Staudt LM, Chan WC (2014) Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 123:1681–1690PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Boveri E, Arcaini L, Merli M, Passamonti F, Rizzi S, Vanelli L, Rumi E, Rattotti S, Lucioni M, Picone C, Castello A, Pascutto C, Magrini U, Lazzarino M, Paulli M (2009) Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol 20:129–136PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Braggio E, Keats JJ, Leleu X, Van WS, Jimenez-Zepeda VH, Valdez R, Schop RF, Price-Troska T, Henderson K, Sacco A, Azab F, Greipp P, Gertz M, Hayman S, Rajkumar SV, Carpten J, Chesi M, Barrett M, Stewart AK, Dogan A, Bergsagel PL, Ghobrial IM, Fonseca R (2009) Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom’s macroglobulinemia. Cancer Res 69:3579–3588PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Braggio E, Philipsborn C, Novak A, Hodge L, Ansell S, Fonseca R (2012) Molecular pathogenesis of Waldenstrom’s macroglobulinemia. Haematologica 97:1281–1290PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Brauninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K, Kuppers R (1999) Identification of common germinal-center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N Engl J Med 340:1239–1247PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Brunner P, Rufle A, Dirnhofer S, Lohri A, Willi N, Cathomas G, Tzankov A, Juskevicius D (2014) Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia 28:1937–1940PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Buggins AG, Levi A, Gohil S, Fishlock K, Patten PE, Calle Y, Yallop D, Devereux S (2011) Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Br J Haematol 154:216–222PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, Bosch F, Montserrat E, Cardesa A, Fernandez PL, Campo E (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 99:238–244PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Camacho FI, Algara P, Mollejo M, Garcia JF, Montalban C, Martinez N, Sanchez-Beato M, Piris MA (2003) Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 27:762–771PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES (1999) Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23:59–68PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Campo E, Catovsky D, Montserrat E, Müller-Hermelink HK, Harris NL et al (2017) In: Swerdlow SH, Campo E, Jaffe ES, Harris NL, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. (Revised 4th ed.) IARC: Lyon, S 222–223Google Scholar
  29. 29.
    Campo E, Pileri SA, Jaffe ES, Nathwani BN, Stein H, Müller-Hermelink HK (2017) Nodal marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: Lyon, S 263–265Google Scholar
  30. 30.
    Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, Montserrat E, Campo E, Banham AH (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108:2957–2964PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E (2012) In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 97:270–278PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Cerroni L, Zenahlik P, Hofler G, Kaddu S, Smolle J, Kerl H (1996) Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 20:1000–1010PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Chan LC, Lam CK, Yeung TC, Chu RW, Ng M, Chow EY, Wickham N, Matutes E (1997) The spectrum of chronic lymphoproliferative disorders in Hong Kong. A prospective study. Leukemia 11:1964–1972PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Chen L, Huynh L, Apgar J, Tang L, Rassenti L, Weiss A, Kipps TJ (2008) ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. Blood 111:2685–2692PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita PM, Strefford JC, Oscier D, Stamatopoulos K, Papadaki T, Berger F, Young KH, Murray F, Rosenquist R, Greiner TC, Chan WC, Orlandi EM, Lucioni M, Marasca R, Inghirami G, Ladetto M, Forconi F, Cogliatti S, Votavova H, Swerdlow SH, Stilgenbauer S, Piris MA, Matolcsy A, Spagnolo D, Nikitin E, Zamo A, Gattei V, Bhagat G, Ott G, Zucca E, Gaidano G, Bertoni F (2013) Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood 122:2673–2682PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF, Gertz MA, Dispenzieri A, Lacy M, Kyle RA, Greipp PR, Tschumper RC, Fonseca R, Bergsagel PL (2006) Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 108:2755–2763PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Chuang SS, Liao YL, Liou CP, Wiggins ML, Ye H, Du MQ, Isaacson PG, Chang CC (2010) Chronic lymphocytic leukemia with paraimmunoblastic transformation - with comparative genomic hybridization and review of the literature. Pathol Res Pract 206:276–281PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Conconi A, Bertoni F, Pedrinis E, Motta T, Roggero E, Luminari S, Capella C, Bonato M, Cavalli F, Zucca E (2001) Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood 98:781–786PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES (2002) In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99:3376–3382CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Cortelazzo S, Ponzoni M, Ferreri AJ, Dreyling M (2012) Mantle cell lymphoma. Crit Rev Oncol Hematol 82:78–101CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Damle RN, Temburni S, Calissano C, Yancopoulos S, Banapour T, Sison C, Allen SL, Rai KR, Chiorazzi N (2007) CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 110:3352–3359PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA, Davies AJ, Norton AJ, Muller-Hermelink HK, Ott G, Campo E, Montserrat E, Wilson WH, Jaffe ES, Simon R, Yang L, Powell J, Zhao H, Goldschmidt N, Chiorazzi M, Staudt LM (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351:2159–2169PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, Norton AJ, Goff LK, Fitzgibbon J, Staudt LM, Andrew LT (2007) Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 136:286–293PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    de Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E (1995) Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10:1833–1840PubMedPubMedCentralGoogle Scholar
  45. 45.
    de Boer JP, Hiddink RF, Raderer M, Antonini N, Aleman BM, Boot H et al (2008) Dissemination patterns in non-gastric MALT lymphoma. Haematologica 93:201–206PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    de Jong D (2005) Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 23:6358–6363PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    de Jong D, Boot H, van Heerde P, Hart GA, Taal BG (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 112:1466–1474PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    de Jong D, Koster A, Hagenbeek A, Raemaekers J, Veldhuizen D, Heisterkamp S, de Boer JP, van Glabbeke M (2009) Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 94:70–77PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    de Jong D, Voetdijk BM, Beverstock GC, van Ommen GJ, Willemze R, Kluin PM (1988) Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318:1373–1378PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Deaglio S, Aydin S, Grand MM, Vaisitti T, Bergui L, D’Arena G, Chiorino G, Malavasi F (2010) CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells. Mol Med 16:87–91PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Dearden C (2012) How I treat prolymphocytic leukemia. Blood 120:538–551PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Del Giudice I, Davis Z, Matutes E, Osuji N, Parry-Jones N, Morilla A, Brito-Babapulle V, Oscier D, Catovsky D (2006) IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL). Leukemia 20:1231–1237PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Del Giudice I, Osuji N, Dexter T, Brito-Babapulle V, Parry-Jones N, Chiaretti S, Messina M, Morgan G, Catovsky D, Matutes E (2009) B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures. Leukemia 23:2160–2167PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Dierlamm J (2003) Genetic abnormalities in marginal zone B-cell lymphoma. Haematologica 88:8–12PubMedPubMedCentralGoogle Scholar
  55. 55.
    Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, Marynen P (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601–3609PubMedPubMedCentralGoogle Scholar
  56. 56.
    Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, Michaux L, Driessen A, Mecucci C, Cassiman JJ, De Wolf-Peeters C, van den Berghe H (1996) Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87:299–307PubMedPubMedCentralGoogle Scholar
  57. 57.
    Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005) Diagnosis and management of Waldenstrom’s macroglobulinemia. J Clin Oncol 23:1564–1577PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Dogan A, Du MQ, Aiello A, Diss TC, Ye HT, Pan LX, Isaacson PG (1998) Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood 91:4708–4714PubMedPubMedCentralGoogle Scholar
  59. 59.
    Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, Dohner K, Bentz M, Lichter P (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910–1916PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L (1996) Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10:1190–1197PubMedPubMedCentralGoogle Scholar
  61. 61.
    Dyer MJ, Zani VJ, Lu WZ, O’Byrne A, Mould S, Chapman R, Heward JM, Kayano H, Jadayel D, Matutes E (1994) BCL2 translocations in leukemias of mature B cells. Blood 83:3682–3688PubMedPubMedCentralGoogle Scholar
  62. 62.
    Endo T, Nishio M, Enzler T, Cottam HB, Fukuda T, James DF, Karin M, Kipps TJ (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 109:703–710PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, Cresta S, Gargiulo E, Forconi F, Guarini A, Arcaini L, Paulli M, Laurenti L, Larocca LM, Marasca R, Gattei V, Oscier D, Bertoni F, Mullighan CG, Foa R, Pasqualucci L, Rabadan R, la-Favera R, Gaidano G (2011) Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 208:1389–1401PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder HW Jr., Ferrarini M, Chiorazzi N (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515–1525PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A, Falcinelli F, Piccioli M, Paulli M, Gambacorta M, Ponzoni M, Tiacci E, Ascani S, Martelli MP, Dalla FR, Stein H, Pileri SA (2012) IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology 61:930–941CrossRefPubMedGoogle Scholar
  66. 66.
    Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, Camos M, Warnke R, Jaffe ES (2008) Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 111:5433–5439PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Fend F, Quintanilla-Martinez L, Kumar S, Beaty MW, Blum L, Sorbara L, Jaffe ES, Raffeld M (1999) Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection. Am J Pathol 154:1857–1866PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A (2005) Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol 23:6364–6369PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, Camacho F, Bea S, Hartmann E, Amador V, Hernandez L, Agostinelli C, Sargent RL, Rozman M, Aymerich M, Colomer D, Villamor N, Swerdlow SH, Pileri SA, Bosch F, Piris MA, Montserrat E, Ott G, Rosenwald A, Lopez-Guillermo A, Jares P, Serrano S, Campo E (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70:1408–1418PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Ferrer A, Salaverria I, Bosch F, Villamor N, Rozman M, Bea S, Gine E, Lopez-Guillermo A, Campo E, Montserrat E (2007) Leukemic involvement is a common feature in mantle cell lymphoma. Cancer 109:2473–2480PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Fisher DE, Jacobson JO, Ault KA, Harris NL (1989) Diffuse large cell lymphoma with discordant bone marrow histology. Clinical features and biological implications. Cancer 64:1879–1887PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM (1995) A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 85:1075–1082PubMedPubMedCentralGoogle Scholar
  73. 73.
    Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, Abdullah S, Olson SB, Spurgeon SE, Fan G (2014) Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. Am J Clin Pathol 142:347–354PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Flossbach L, Holzmann K, Mattfeldt T, Buck M, Lanz K, Held M, Moller P, Barth TF (2013) High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant. Int J Cancer 132:E116–E127PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Fong D, Kaiser A, Spizzo G, Gastl G, Tzankov A (2005) Hodgkin’s disease variant of Richter’s syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. Br J Haematol 129:199–205PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Fonseca R, Hayman S (2007) Waldenstrom macroglobulinaemia. Br J Haematol 138:700–720PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Frater JL, McCarron KF, Hammel JP, Shapiro JL, Miller ML, Tubbs RR, Pettay J, Hsi ED (2001) Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol 116:655–664PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, de Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Muller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC (2005) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 106:4315–4321PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, age-Corre M, Coste V, Laforet MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogne M, Feuillard J (2013) IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia 27:183–189PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Galton DA, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ (1974) Prolymphocytic leukaemia. Br J Haematol 27:7–23PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Ghobrial IM, Fonseca R, Gertz MA, Plevak MF, Larson DR, Therneau TM, Wolf RC, Hoffmann RJ, Lust JA, Witzig TE, Lacy MQ, Dispenzieri A, Vincent RS, Zeldenrust SR, Greipp PR, Kyle RA (2006) Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. Br J Haematol 133:158–164PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntanola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E (2010) Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia („accelerated“ chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95:1526–1533PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA, van Laar R, van Krieken JH, Baars JW, Raemaekers J, Kluin PM, van’t Veer LJ, de Jong D (2007) Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 25:390–398PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Gonzalez CL, Medeiros LJ, Jaffe ES (1991) Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin’s disease and B-cell non-Hodgkin’s lymphoma. Am J Clin Pathol 96:81–89PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Gonzalez D, Martinez P, Wade R, Hockley S, Oscier D, Matutes E, Dearden CE, Richards SM, Catovsky D, Morgan GJ (2011) Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. J Clin Oncol 29:2223–2229PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Gould SJ, Isaacson PG (1993) Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung. J Pathol 169:229–234PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Gupta D, Lim MS, Medeiros LJ, Elenitoba-Johnson KS (2000) Small lymphocytic lymphoma with perifollicular, marginal zone, or interfollicular distribution. Mod Pathol 13:1161–1166PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Gutierrez A Jr., Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston PM III, Slager SL, Kay NE, Jelinek DF (2010) LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 116:2975–2983PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Gutierrez NC, Ocio EM, de Las RJ, Maiso P, Delgado M, Ferminan E, Arcos MJ, Sanchez ML, Hernandez JM, San Miguel JF (2007) Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom’s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 21:541–549PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446–5456PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Haralambieva E, Adam P, Ventura R, Katzenberger T, Kalla J, Holler S, Hartmann M, Rosenwald A, Greiner A, Muller-Hermelink HK, Banham AH, Ott G (2006) Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia 20:1300–1303PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Jaffe ES, Harris NL, Swerdlow SH, Ott G, Nathwani et al (2017) Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: Lyon, S 267–277Google Scholar
  93. 93.
    Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Bea S, Rosenwald A (2010) Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood 116:953–961PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Henopp T, Quintanilla-Martinez L, Fend F, Adam P (2011) Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 59:139–142CrossRefGoogle Scholar
  95. 95.
    Hercher C, Robain M, Davi F, Garand R, Flandrin G, Valensi F, Vandeputte H, Albert A, Maynadie M, Troussard X, Simon GH, Lespinasse J, Portefaix G, Merle-Beral H (2001) A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive forms. Leuk Lymphoma 42:981–987PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Hernandez L, Bea S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, Lopez-Guillermo A, Delabie J, Colomer D, Montserrat E, Campo E (2005) CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Cancer Res 65:2199–2206PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 87:3351–3359PubMedPubMedCentralGoogle Scholar
  98. 98.
    Hicks EB, Rappaport H, Winter WJ (1956) Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9:792–821PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G (2004) Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 104:904–905PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Hoglund M, Sehn L, Connors JM, Gascoyne RD, Siebert R, Sall T, Mitelman F, Horsman DE (2004) Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 39:195–204PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, Kalla J, Romero M, Siebert R, Rosenwald A, Ott G (2011) Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica 96:1327–1334PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Horsman DE, Connors JM, Pantzar T, Gascoyne RD (2001) Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 30:375–382PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Huh YO, Lin KI, Vega F, Schlette E, Yin CC, Keating MJ, Luthra R, Medeiros LJ, Abruzzo LV (2008) MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol 142:36–44PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Hummel M, Oeschger S, Barth TF, Loddenkemper C, Cogliatti SB, Marx A, Wacker HH, Feller AC, Bernd HW, Hansmann ML, Stein H, Moller P (2006) Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut 55:782–787PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Hussell T, Isaacson PG, Crabtree JE, Spencer J (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571–574PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Hyjek E, Isaacson PG (1988) Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Hum Pathol 19:1315–1326PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Hyjek E, Smith WJ, Isaacson PG (1988) Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 19:766–776PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Cook JR, Isaacson PG, Chott A, Nakamura S, Müller-Hermelink HK et al (2017) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: Lyon, S 259–262Google Scholar
  109. 109.
    Isaacson PG, Du MQ (2004) MALT lymphoma: from morphology to molecules. Nat Rev Cancer 4:644–653PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Isaacson PG, Wotherspoon AC, Diss T, Pan LX (1991) Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol 15:819–828PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Isaacson P (2001) Gastrointestinal lymphoma and lymphoid hyperplasias. In: Knowles D (Hrsg) Neoplastic hematopathology. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  112. 112.
    Ishii Y, Tomita N, Suzuki T, Ishiyama Y, Kishimoto K, Yamamoto E, Koyama S, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Takemura S, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y (2015) Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. Leuk Lymphoma 56(9):2750–2PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Jares P, Colomer D, Campo E (2012) Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 122:3416–3423PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, Jaffe ES (2011) Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood 118:2976–2984PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 114:2273–2279PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Kanzler H, Kuppers R, Helmes S, Wacker HH, Chott A, Hansmann ML, Rajewsky K (2000) Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin’s disease. Blood 95:1023–1031PubMedPubMedCentralGoogle Scholar
  117. 117.
    Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Takeshita M, Kikuchi M, Nakamura N, Takasu O, Arakawa F, Tagawa H, Seto M, Ohshima K (2007) CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 109:3076–3079PubMedPubMedCentralGoogle Scholar
  118. 118.
    Katzenberger T, Kalla J, Leich E, Stocklein H, Hartmann E, Barnickel S, Wessendorf S, Ott MM, Muller-Hermelink HK, Rosenwald A, Ott G (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113:1053–1061PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Katzenberger T, Petzoldt C, Holler S, Mader U, Kalla J, Adam P, Ott MM, Muller-Hermelink HK, Rosenwald A, Ott G (2006) The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 107:3407PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Klapper W, Hoster E, Determann O, Oschlies I, van der Laak J, Berger F, Bernd HW, Cabecadas J, Campo E, Cogliatti S, Hansmann ML, Kluin PM, Kodet R, Krivolapov YA, Loddenkemper C, Stein H, Moller P, Barth TE, Muller-Hermelink K, Rosenwald A, Ott G, Pileri S, Ralfkiaer E, Rymkiewicz G, van Krieken JH, Wacker HH, Unterhalt M, Hiddemann W, Dreyling M (2009) Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network. J Hematop 2:103–111PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Klapper W, Hoster E, Rolver L, Schrader C, Janssen D, Tiemann M, Bernd HW, Determann O, Hansmann ML, Moller P, Feller A, Stein H, Wacker HH, Dreyling M, Unterhalt M, Hiddemann W, Ott G (2007) Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. J Clin Oncol 25:3330–3336PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Kluin PM (2013) Origin and migration of follicular lymphoma cells. Haematologica 98:1331–1333PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth TF, Moller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Dohner H, Lichter P, Bentz M (2004) Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104:795–801PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Koster A, Tromp HA, Raemaekers JM, Borm GF, Hebeda K, Mackenzie MA, van Krieken JH (2007) The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma. Haematologica 92:184–190PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C, Ben-Neriah S, Tan K, Morin RD, Opat S, Sehn LH, Connors JM, Marra MA, Weng AP, Steidl C, Gascoyne RD (2012) Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119:1963–1971PubMedPubMedCentralCrossRefGoogle Scholar
  126. 126.
    Krijgsman O, Gonzalez P, Ponz OB, Roemer MG, Slot S, Broeks A, Braaf L, Kerkhoven RM, Bot F, van Groningen K, Beijert M, Ylstra B, de Jong D (2013) Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features. Haematologica 98:1921–1929PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Kroft SH, Dawson DB, McKenna RW (2001) Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases. Am J Clin Pathol 115:385–395PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Kussick SJ, Kalnoski M, Braziel RM, Wood BL (2004) Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 121:464–472PubMedPubMedCentralCrossRefGoogle Scholar
  129. 129.
    Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ (2013) Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152:714–726PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE (2009) B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 360:659–667PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    Laszlo T, Matolcsy A (1999) Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour. Histopathology 35:355–359PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, Gauduchon P (2009) t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia 23:1190–1193CrossRefPubMedGoogle Scholar
  133. 133.
    Lee AM, Clear AJ, Calaminici M, Davies AJ, Jordan S, MacDougall F, Matthews J, Norton AJ, Gribben JG, Lister TA, Goff LK (2006) Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 24:5052–5059PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Lennert K, Stein H, Kaiserling E (1975) Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer Suppl 2:29–43PubMedPubMedCentralGoogle Scholar
  135. 135.
    Lennert K, Feller AC (1992) Histopathology of Non-Hodgkin lymphomas. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  136. 136.
    Lens D, Coignet LJ, Brito-Babapulle V, Lima CS, Matutes E, Dyer MJ, Catovsky D (1999) B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene. Leukemia 13:873–876PubMedPubMedCentralCrossRefGoogle Scholar
  137. 137.
    Lens D, De Schouwer PJ, Hamoudi RA, bdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJ, Catovsky D (1997) p53 abnormalities in B-cell prolymphocytic leukemia. Blood 89:2015–2023PubMedPubMedCentralGoogle Scholar
  138. 138.
    Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ (2003) Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 120:246–253CrossRefPubMedGoogle Scholar
  139. 139.
    Linet MS, Schubauer-Berigan MK, Weisenburger DD, Richardson DB, Landgren O, Blair A, Silver S, Field RW, Caldwell G, Hatch M, Dores GM (2007) Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol 139:672–686PubMedPubMedCentralCrossRefGoogle Scholar
  140. 140.
    Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, Isaacson PG (2001) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357:39–40CrossRefPubMedGoogle Scholar
  141. 141.
    Lo CF, Gaidano G, Louie DC, Offit K, Chaganti RS, la-Favera R (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289–2295Google Scholar
  142. 142.
    Loeffler M, Kreuz M, Haake A, Hasenclever D, Trautmann H, Arnold C, Winter K, Koch K, Klapper W, Scholtysik R, Rosolowski M, Hoffmann S, Ammerpohl O, Szczepanowski M, Herrmann D, Kuppers R, Pott C, Siebert R (2015) Genomic and epigenomic co-evolution in follicular lymphomas. Leukemia 29:456–463CrossRefPubMedGoogle Scholar
  143. 143.
    Lorsbach RB, Shay-Seymore D, Moore J, Banks PM, Hasserjian RP, Sandlund JT, Behm FG (2002) Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 99:1959–1964CrossRefPubMedGoogle Scholar
  144. 144.
    Lossos IS, Gascoyne RD (2011) Transformation of follicular lymphoma. Best Pract Res Clin Haematol 24:147–163PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Louissaint A Jr., Ackerman AM, as-Santagata D, Ferry JA, Hochberg EP, Huang MS, Iafrate AJ, Lara DO, Pinkus GS, Salaverria I, Siddiquee Z, Siebert R, Weinstein HJ, Zukerberg LR, Harris NL, Hasserjian RP (2012) Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood 120:2395–2404CrossRefPubMedGoogle Scholar
  146. 146.
    Malcikova J, Pavlova S, Kozubik KS, Pospisilova S (2014) TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia. Hum Mutat 35:663–671CrossRefPubMedGoogle Scholar
  147. 147.
    Malcikova J, Stano-Kozubik K, Tichy B, Kantorova B, Pavlova S, Tom N, Radova L, Smardova J, Pardy F, Doubek M, Brychtova Y, Mraz M, Plevova K, Diviskova E, Oltova A, Mayer J, Pospisilova S, Trbusek M (2015) Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. Leukemia 29:877–885CrossRefPubMedGoogle Scholar
  148. 148.
    Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaide J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B (2014) Early lesions of follicular lymphoma: a genetic perspective. Haematologica 99:481–488PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Mann RB, Berard CW (1983) Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol 1:187–192CrossRefPubMedGoogle Scholar
  150. 150.
    Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Muller-Hermelink HK, Ott G, Fend F, Rosenwald A (2007) IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605–1614CrossRefPubMedPubMedCentralGoogle Scholar
  151. 151.
    Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Huhn D, Stein H (1999) Classical Hodgkin’s disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 17:3804–3809PubMedPubMedCentralCrossRefGoogle Scholar
  152. 152.
    Marafioti T, Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M, Plonquet A, Rodriguez-Pinilla SM, Klapper W, Hansmann ML, Pileri SA, Isaacson PG, Stein H, Piris MA, Mason DY, Gaulard P (2010) The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica 95:432–439PubMedPubMedCentralCrossRefGoogle Scholar
  153. 153.
    Martin-Jimenez P, Garcia-Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sanchez ML, Gonzalez M, San MJ (2007) Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstrom’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Haematologica 92:635–642CrossRefPubMedGoogle Scholar
  154. 154.
    Martinez D, Valera A, Perez NS, Sua Villegas LF, Gonzalez-Farre B, Sole C, Gine E, Lopez-Guillermo A, Roue G, Martinez S, Sant F, Warzocha K, Robak T, Czader M, Villamor N, Colomo L, Campo E, Martinez A (2013) Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases. Am J Surg Pathol 37:272–281CrossRefPubMedGoogle Scholar
  155. 155.
    Matutes E, Owusu-Ankomah K, Morilla R, Garcia MJ, Houlihan A, Que TH, Catovsky D (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640–1645PubMedGoogle Scholar
  156. 156.
    Mauro FR, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E, Sala R, Cerretti R, Mandelli F (1999) Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 94:448–454PubMedGoogle Scholar
  157. 157.
    Melo JV, Catovsky D, Galton DA (1986) The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol 63:377–387CrossRefPubMedGoogle Scholar
  158. 158.
    Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ (2003) Mature B-cell leukemias with more than 55 % prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 127:305–309PubMedGoogle Scholar
  159. 159.
    Morabito F, Mosca L, Cutrona G, Agnelli L, Tuana G, Ferracin M, Zagatti B, Lionetti M, Fabris S, Maura F, Matis S, Gentile M, Vigna E, Colombo M, Massucco C, Recchia AG, Bossio S, De SL, Ilariucci F, Musolino C, Molica S, Di RF, Cortelezzi A, Tassone P, Negrini M, Monti S, Rossi D, Gaidano G, Ferrarini M, Neri A (2013) Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res 19:5890–5900CrossRefPubMedGoogle Scholar
  160. 160.
    Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298–303PubMedPubMedCentralCrossRefGoogle Scholar
  161. 161.
    Morse HC III, Kearney JF, Isaacson PG, Carroll M, Fredrickson TN, Jaffe ES (2001) Cells of the marginal zone – origins, function and neoplasia. Leuk Res 25:169–178CrossRefPubMedGoogle Scholar
  162. 162.
    Mozos A, Royo C, Hartmann E, de Jong D, Baro C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Sole F, Lopez-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94:1555–1562PubMedPubMedCentralCrossRefGoogle Scholar
  163. 163.
    Campo E, Ghia P, Montserrat E, Harris NL, Müller-Hermelink HK et al (2017) Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: Lyon, S 216–221Google Scholar
  164. 164.
    Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T, Sakai Y, Fuchigami T, Yamamoto I, Tsuneyoshi M, Fujishima M (1998) B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 152:1271–1279PubMedPubMedCentralGoogle Scholar
  165. 165.
    Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M (1997) Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 79:3–11CrossRefPubMedGoogle Scholar
  166. 166.
    Naresh KN (2007) MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes. Haematologica 92:267–268CrossRefPubMedGoogle Scholar
  167. 167.
    Naresh KN (2008) Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases. Histopathology 52:331–339CrossRefPubMedGoogle Scholar
  168. 168.
    Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, Harris NL, MacLennan KA, Muller-Hermelink HK, Ullrich FA, Weisenburger DD (1999) Clinical significance of follicular lymphoma with monocytoid B cells. Non-Hodgkin’s Lymphoma Classification Project. Hum Pathol 30:263–268CrossRefPubMedGoogle Scholar
  169. 169.
    Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, Harris NL, MacLennan KA, Muller-Hermelink HK, Ullrich FA, Weisenburger DD (1999) Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol 17:2486–2492CrossRefPubMedGoogle Scholar
  170. 170.
    Navarro A, Clot G, Royo C, Jares P, Hadzidimitriou A, Agathangelidis A, Bikos V, Darzentas N, Papadaki T, Salaverria I, Pinyol M, Puig X, Palomero J, Vegliante MC, Amador V, Martinez-Trillos A, Stefancikova L, Wiestner A, Wilson W, Pott C, Calasanz MJ, Trim N, Erber W, Sander B, Ott G, Rosenwald A, Colomer D, Gine E, Siebert R, Lopez-Guillermo A, Stamatopoulos K, Bea S, Campo E (2012) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 72:5307–5316PubMedPubMedCentralCrossRefGoogle Scholar
  171. 171.
    Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470:115–119CrossRefPubMedGoogle Scholar
  172. 172.
    Nguyen-Khac F, Lejeune J, Chapiro E, Mould S, Barin C, Daudignon A (2010) Cytogenetic abnormalities in a cohort of 171 patients with Waldenström macroglobulinemia before treatment: clinical and biological correlations. Blood ASH Annual Meeting Abstracts. Bd. 116Google Scholar
  173. 173.
    Norton AJ, Matthews J, Pappa V, Shamash J, Love S, Rohatiner AZ, Lister TA (1995) Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249–256CrossRefPubMedGoogle Scholar
  174. 174.
    Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, la-Favera R, Pasqualucci L, Bhagat G, Bertoni F (2009) The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 113:4918–4921PubMedPubMedCentralCrossRefGoogle Scholar
  175. 175.
    Offit K, Louie DC, Parsa NZ, Noy A, Chaganti RS (1995) Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood 86:2365–2370PubMedPubMedCentralGoogle Scholar
  176. 176.
    Ohno T, Smir BN, Weisenburger DD, Gascoyne RD, Hinrichs SD, Chan WC (1998) Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin’s transformation”. Blood 91:1757–1761PubMedPubMedCentralGoogle Scholar
  177. 177.
    Okosun J, Bodor C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D, Bozek M, Iqbal S, Matthews J, Wrench D, Marzec J, Tawana K, Popov N, O’Riain C, O’Shea D, Carlotti E, Davies A, Lawrie CH, Matolcsy A, Calaminici M, Norton A, Byers RJ, Mein C, Stupka E, Lister TA, Lenz G, Montoto S, Gribben JG, Fan Y, Grosschedl R, Chelala C, Fitzgibbon J (2014) Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet 46:176–181PubMedPubMedCentralCrossRefGoogle Scholar
  178. 178.
    Omoti CE, Omoti AE (2008) Richter syndrome: a review of clinical, ocular, neurological and other manifestations. Br J Haematol 142:709–716PubMedPubMedCentralCrossRefGoogle Scholar
  179. 179.
    Ondrejka SL, Lai R, Smith SD, Hsi ED (2011) Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 96:1121–1127PubMedPubMedCentralCrossRefGoogle Scholar
  180. 180.
    Oscier DG, Matutes E, Copplestone A, Pickering RM, Chapman R, Gillingham R, Catovsky D, Hamblin TJ (1997) Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 98:934–939PubMedPubMedCentralCrossRefGoogle Scholar
  181. 181.
    Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, Muller JG, Muller-Hermelink HK (1997) Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89:1421–1429PubMedPubMedCentralGoogle Scholar
  182. 182.
    Ott G, Kalla J, Steinhoff A, Rosenwald A, Katzenberger T, Roblick U, Ott MM, Muller-Hermelink HK (1998) Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol 153:689–694PubMedPubMedCentralCrossRefGoogle Scholar
  183. 183.
    Ott G, Katzenberger T, Greiner A, Kalla J, Rosenwald A, Heinrich U, Ott MM, Muller-Hermelink HK (1997) The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin’s lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57:3944–3948PubMedPubMedCentralGoogle Scholar
  184. 184.
    Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M, Kalla J, Rosenwald A, Muller JG, Ott MM, Muller-Hermelink HK (2002) Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 99:3806–3812PubMedPubMedCentralCrossRefGoogle Scholar
  185. 185.
    Ott G, Leich E, Rosenwald A, Nadel B (2014) Follicular lymphoma. In: McManus LM, Mitchell RN (Hrsg) Pathobiology of human disease. Elsevier, San Diego, S 1720–1731CrossRefGoogle Scholar
  186. 186.
    Ott MM, Helbing A, Ott G, Bartek J, Fischer L, Durr A, Kreipe H, Muller-Hermelink HK (1996) bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 179:238–242PubMedPubMedCentralCrossRefGoogle Scholar
  187. 187.
    Ott MM, Ott G, Kuse R, Porowski P, Gunzer U, Feller AC, Muller-Hermelink HK (1994) The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 24:329–334PubMedPubMedCentralCrossRefGoogle Scholar
  188. 188.
    Ott MM, Rosenwald A, Katzenberger T, Dreyling M, Krumdiek AK, Kalla J, Greiner A, Ott G, Muller-Hermelink HK (2000) Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities. Genes Chromosomes Cancer 28:380–386PubMedPubMedCentralCrossRefGoogle Scholar
  189. 189.
    Palomero J, Vegliante MC, Rodriguez ML, Eguileor A, Castellano G, Planas-Rigol E, Jares P, Ribera-Cortada I, Cid MC, Campo E, Amador V (2014) SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma. Blood 124:2235–2247PubMedPubMedCentralCrossRefGoogle Scholar
  190. 190.
    Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271PubMedPubMedCentralCrossRefGoogle Scholar
  191. 191.
    Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, la-Favera R (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189–195PubMedPubMedCentralCrossRefGoogle Scholar
  192. 192.
    Perez-Galan P, Dreyling M, Wiestner A (2011) Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 117:26–38PubMedPubMedCentralCrossRefGoogle Scholar
  193. 193.
    Piccaluga PP, Califano A, Klein U, Agostinelli C, Bellosillo B, Gimeno E, Serrano S, Sole F, Zang Y, Falini B, Zinzani PL, Pileri SA (2008) Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica 93:1033–1038PubMedPubMedCentralCrossRefGoogle Scholar
  194. 194.
    Pileri SA, Sabattini E, Rosito P, Zinzani PL, Ascani S, Fraternali-Orcioni G, Gamberi B, Piccioli M, Vivenza D, Falini B, Gaidano G (2002) Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics. J Clin Pathol 55:684–688PubMedPubMedCentralCrossRefGoogle Scholar
  195. 195.
    Pillai RK, Surti U, Swerdlow SH (2013) Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies. Haematologica 98:1571–1580PubMedPubMedCentralCrossRefGoogle Scholar
  196. 196.
    Pinyol M, Bea S, Pla L, Ribrag V, Bosq J, Rosenwald A, Campo E, Jares P (2007) Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood 109:5422–5429PubMedPubMedCentralCrossRefGoogle Scholar
  197. 197.
    Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL, Montserrat E, Cardesa A, Campo E (1998) p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin’s lymphomas. Blood 91:2977–2984PubMedPubMedCentralGoogle Scholar
  198. 198.
    Pinyol M, Hernandez L, Cazorla M, Balbin M, Jares P, Fernandez PL, Montserrat E, Cardesa A, Lopez-Otin C, Campo E (1997) Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 89:272–280PubMedPubMedCentralGoogle Scholar
  199. 199.
    Pospisilova S, Gonzalez D, Malcikova J, Trbusek M, Rossi D, Kater AP, Cymbalista F, Eichhorst B, Hallek M, Dohner H, Hillmen P, van OM, Gribben J, Ghia P, Montserrat E, Stilgenbauer S, Zenz T (2012) ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia 26:1458–1461PubMedPubMedCentralCrossRefGoogle Scholar
  200. 200.
    Pruneri G, Valentini S, Bertolini F, Del CB, Maiorano E, Viale G (2005) SP4, a novel anti-cyclin D1 rabbit monoclonal antibody, is a highly sensitive probe for identifying mantle cell lymphomas bearing the t(11;14)(q13;q32) translocation. Appl Immunohistochem Mol Morphol 13:318–322PubMedPubMedCentralCrossRefGoogle Scholar
  201. 201.
    Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N, Escaramis G, Jares P, Bea S, Gonzalez-Diaz M, Bassaganyas L, Baumann T, Juan M, Lopez-Guerra M, Colomer D, Tubio JM, Lopez C, Navarro A, Tornador C, Aymerich M, Rozman M, Hernandez JM, Puente DA, Freije JM, Velasco G, Gutierrez-Fernandez A, Costa D, Carrio A, Guijarro S, Enjuanes A, Hernandez L, Yague J, Nicolas P, Romeo-Casabona CM, Himmelbauer H, Castillo E, Dohm JC, de SS, Piris MA, de AE, San MJ, Royo R, Gelpi JL, Torrents D, Orozco M, Pisano DG, Valencia A, Guigo R, Bayes M, Heath S, Gut M, Klatt P, Marshall J, Raine K, Stebbings LA, Futreal PA, Stratton MR, Campbell PJ, Gut I, Lopez-Guillermo A, Estivill X, Montserrat E, Lopez-Otin C, Campo E (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101–105PubMedPubMedCentralCrossRefGoogle Scholar
  202. 202.
    Put N, Van RK, Konings P, Meeus P, Brusselmans C, Rack K, Gervais C, Nguyen-Khac F, Chapiro E, Radford-Weiss I, Struski S, Dastugue N, Gachard N, Lefebvre C, Barin C, Eclache V, Fert-Ferrer S, Laibe S, Mozziconacci MJ, Quilichini B, Poirel HA, Wlodarska I, Hagemeijer A, Moreau Y, Vandenberghe P, Michaux L (2012) Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol 91:863–873PubMedPubMedCentralCrossRefGoogle Scholar
  203. 203.
    Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Muller-Hermelink HK (1995) Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 86:3528–3534PubMedPubMedCentralGoogle Scholar
  204. 204.
    Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L, Ramsay AJ, Bea S, Pinyol M, Martinez-Trillos A, Lopez-Guerra M, Colomer D, Navarro A, Baumann T, Aymerich M, Rozman M, Delgado J, Gine E, Hernandez JM, Gonzalez-Diaz M, Puente DA, Velasco G, Freije JM, Tubio JM, Royo R, Gelpi JL, Orozco M, Pisano DG, Zamora J, Vazquez M, Valencia A, Himmelbauer H, Bayes M, Heath S, Gut M, Gut I, Estivill X, Lopez-Guillermo A, Puente XS, Campo E, Lopez-Otin C (2012) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44:47–52CrossRefGoogle Scholar
  205. 205.
    Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E, Jaffe ES, Raffeld M (1998) Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 153:175–182PubMedPubMedCentralCrossRefGoogle Scholar
  206. 206.
    Radcliffe CM, Arnold JN, Suter DM, Wormald MR, Harvey DJ, Royle L, Mimura Y, Kimura Y, Sim RB, Inoges S, Rodriguez-Calvillo M, Zabalegui N, de Cerio AL, Potter KN, Mockridge CI, Dwek RA, Bendandi M, Rudd PM, Stevenson FK (2007) Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J Biol Chem 282:7405–7415PubMedPubMedCentralCrossRefGoogle Scholar
  207. 207.
    Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, Chott A (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11:3349–3352PubMedPubMedCentralCrossRefGoogle Scholar
  208. 208.
    Randen U, Tierens AM, Tjonnfjord GE, Delabie J (2013) Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns. Am J Clin Pathol 139:390–395PubMedPubMedCentralCrossRefGoogle Scholar
  209. 209.
    Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A, Hillmen P, Ghia P (2010) Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytom B Clin Cytom 78(Suppl 1):S19–S23CrossRefGoogle Scholar
  210. 210.
    Reiniger L, Bodor C, Bognar A, Balogh Z, Csomor J, Szepesi A, Kopper L, Matolcsy A (2006) Richter’s and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 20:1089–1095PubMedPubMedCentralCrossRefGoogle Scholar
  211. 211.
    Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, Law M, Dewald GW, Kurtin PJ (2006) The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 30:1546–1553PubMedPubMedCentralCrossRefGoogle Scholar
  212. 212.
    Richter MN (1928) Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 4:285–292PubMedPubMedCentralGoogle Scholar
  213. 213.
    Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, Rancoita PM, De Campos CP, Forconi F, Gascoyne RD, Facchetti F, Ponzoni M, Govi S, Ferreri AJ, Mollejo M, Piris MA, Baldini L, Soulier J, Thieblemont C, Canzonieri V, Gattei V, Marasca R, Franceschetti S, Gaidano G, Tucci A, Uccella S, Tibiletti MG, Dirnhofer S, Tripodo C, Doglioni C, Dalla FR, Cavalli F, Zucca E, Kwee I, Bertoni F (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 117:1595–1604PubMedPubMedCentralCrossRefGoogle Scholar
  214. 214.
    Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES (2010) Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol 23:866–873CrossRefGoogle Scholar
  215. 215.
    Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, Younes A, McLaughlin P, Goy A, Sarris AH, Dang NH, Samaniego F, Brown HM, Gagneja HK, Cabanillas F (2003) Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer 97:586–591PubMedPubMedCentralCrossRefGoogle Scholar
  216. 216.
    Rosales CM, Lin P, Mansoor A, Bueso-Ramos C, Medeiros LJ (2001) Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia associated with Hodgkin disease. A report of two cases. Am J Clin Pathol 116:34–40PubMedPubMedCentralCrossRefGoogle Scholar
  217. 217.
    Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639–1647PubMedPubMedCentralCrossRefGoogle Scholar
  218. 218.
    Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185–197PubMedPubMedCentralCrossRefGoogle Scholar
  219. 219.
    Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M, Fangazio M, Vaisitti T, Monti S, Chiaretti S, Guarini A, del Giudice I, Cerri M, Cresta S, Deambrogi C, Gargiulo E, Gattei V, Forconi F, Bertoni F, Deaglio S, Rabadan R, Pasqualucci L, Foa R, la-Favera R, Gaidano G (2011) Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 118:6904–6908PubMedPubMedCentralCrossRefGoogle Scholar
  220. 220.
    Rossi D, Cerri M, Capello D, Deambrogi C, Rossi FM, Zucchetto A, De PL, Cresta S, Rasi S, Spina V, Franceschetti S, Lunghi M, Vendramin C, Bomben R, Ramponi A, Monga G, Conconi A, Magnani C, Gattei V, Gaidano G (2008) Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 142:202–215PubMedPubMedCentralCrossRefGoogle Scholar
  221. 221.
    Rossi D, Fangazio M, Rasi S, Vaisitti T, Monti S, Cresta S, Chiaretti S, del Giudice I, Fabbri G, Bruscaggin A, Spina V, Deambrogi C, Marinelli M, Fama R, Greco M, Daniele G, Forconi F, Gattei V, Bertoni F, Deaglio S, Pasqualucci L, Guarini A, la-Favera R, Foa R, Gaidano G (2012) Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 119:2854–2862PubMedPubMedCentralCrossRefGoogle Scholar
  222. 222.
    Rossi D, Khiabanian H, Spina V, Ciardullo C, Bruscaggin A, Fama R, Rasi S, Monti S, Deambrogi C, De PL, Wang J, Gattei V, Guarini A, Foa R, Rabadan R, Gaidano G (2014) Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood 123:2139–2147PubMedPubMedCentralCrossRefGoogle Scholar
  223. 223.
    Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Fama R, De PL, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, la-Favera R, Foa R, Gaidano G (2012) Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119:521–529PubMedPubMedCentralCrossRefGoogle Scholar
  224. 224.
    Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foa R, Young KH, Gaidano G (2011) The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117:3391–3401PubMedPubMedCentralCrossRefGoogle Scholar
  225. 225.
    Roulland S, Navarro JM, Grenot P, Milili M, Agopian J, Montpellier B, Gauduchon P, Lebailly P, Schiff C, Nadel B (2006) Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 203:2425–2431PubMedPubMedCentralCrossRefGoogle Scholar
  226. 226.
    Royo C, Navarro A, Clot G, Salaverria I, Gine E, Jares P, Colomer D, Wiestner A, Wilson WH, Vegliante MC, Fernandez V, Hartmann EM, Trim N, Erber WN, Swerdlow SH, Klapper W, Dyer MJ, Vargas-Pabon M, Ott G, Rosenwald A, Siebert R, Lopez-Guillermo A, Campo E, Bea S (2012) Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia 26:1895–1898PubMedPubMedCentralCrossRefGoogle Scholar
  227. 227.
    Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D (2004) B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol 125:330–336PubMedPubMedCentralCrossRefGoogle Scholar
  228. 228.
    Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L, Raffeld M (2006) Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108:1668–1676PubMedPubMedCentralCrossRefGoogle Scholar
  229. 229.
    Sakata-Yanagimoto M, Enami T, Yokoyama Y, Chiba S (2014) Disease-specific mutations in mature lymphoid neoplasms: recent advances. Cancer Sci 105:623–629PubMedPubMedCentralCrossRefGoogle Scholar
  230. 230.
    Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M, Burkhardt B, Trautmann H, Gesk S, Andrusiewicz M, Berger H, Fey M, Harder L, Hasenclever D, Hummel M, Loeffler M, Mahn F, Martin-Guerrero I, Pellissery S, Pott C, Pfreundschuh M, Reiter A, Richter J, Rosolowski M, Schwaenen C, Stein H, Trumper L, Wessendorf S, Spang R, Kuppers R, Klapper W, Siebert R (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118:139–147CrossRefPubMedPubMedCentralGoogle Scholar
  231. 231.
    Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W, Hartmann EM, Sujobert P, Wlodarska I, Ferry JA, Gaulard P, Ott G, Rosenwald A, Lopez-Guillermo A, Quintanilla-Martinez L, Harris NL, Jaffe ES, Siebert R, Campo E, Bea S (2013) CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood 121:1394–1402PubMedPubMedCentralCrossRefGoogle Scholar
  232. 232.
    Salaverria I, Zettl A, Bea S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007) Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 25:1216–1222PubMedPubMedCentralCrossRefGoogle Scholar
  233. 233.
    Sanchez-Izquierdo D, Buchonnet G, Siebert R, Gascoyne RD, Climent J, Karran L, Marin M, Blesa D, Horsman D, Rosenwald A, Staudt LM, Albertson DG, Du MQ, Ye H, Marynen P, Garcia-Conde J, Pinkel D, Dyer MJ, Martinez-Climent JA (2003) MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101:4539–4546PubMedPubMedCentralCrossRefGoogle Scholar
  234. 234.
    Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994–2004PubMedPubMedCentralGoogle Scholar
  235. 235.
    Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A 97:2773–2778PubMedPubMedCentralCrossRefGoogle Scholar
  236. 236.
    Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ (2001) Mature B-cell leukemias with more than 55 % prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol 115:571–581PubMedPubMedCentralCrossRefGoogle Scholar
  237. 237.
    Schmatz AI, Streubel B, Kretschmer-Chott E, Puspok A, Jager U, Mannhalter C, Tiemann M, Ott G, Fischbach W, Herzog P, Seitz G, Stolte M, Raderer M, Chott A (2011) Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 29:1445–1451CrossRefPubMedGoogle Scholar
  238. 238.
    Schmidt J, Gong S, Marafioti T, Mankel B, Gonzalez-Farre B, Balague O, Mozos A, Cabecadas J, van der WJ, Hoehn D, Rosenwald A, Ott G, Dojcinov S, Egan C, Nadeu F, Ramis-Zaldivar JE, Clot G, Barcena C, Perez-Alonso V, Endris V, Penzel R, Lome-Maldonado C, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L (2016) Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. Blood 128:1101–1111PubMedPubMedCentralCrossRefGoogle Scholar
  239. 239.
    Schmidt J, Salaverria I, Haake A, Bonzheim I, Adam P, Montes-Moreno S, Piris MA, Fend F, Siebert R, Quintanilla-Martinez L (2014) Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma. Leukemia 28:1103–1112PubMedPubMedCentralCrossRefGoogle Scholar
  240. 240.
    Schuh A, Becq J, Humphray S, Alexa A, Burns A, Clifford R, Feller SM, Grocock R, Henderson S, Khrebtukova I, Kingsbury Z, Luo S, McBride D, Murray L, Menju T, Timbs A, Ross M, Taylor J, Bentley D (2012) Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120:4191–4196PubMedPubMedCentralCrossRefGoogle Scholar
  241. 241.
    Schwaenen C, Viardot A, Berger H, Barth TF, Bentink S, Dohner H, Enz M, Feller AC, Hansmann ML, Hummel M, Kestler HA, Klapper W, Kreuz M, Lenze D, Loeffler M, Moller P, Muller-Hermelink HK, Ott G, Rosolowski M, Rosenwald A, Ruf S, Siebert R, Spang R, Stein H, Truemper L, Lichter P, Bentz M, Wessendorf S (2009) Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer 48:39–54PubMedPubMedCentralCrossRefGoogle Scholar
  242. 242.
    Schwartz JB, Shamsuddin AM (1981) The effects of leukemic infiltrates in various organs in chronic lymphocytic leukemia. Hum Pathol 12:432–440PubMedPubMedCentralCrossRefGoogle Scholar
  243. 243.
    Shia J, Teruya-Feldstein J, Pan D, Hegde A, Klimstra DS, Chaganti RS, Qin J, Portlock CS, Filippa DA (2002) Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol 26:216–224PubMedPubMedCentralCrossRefGoogle Scholar
  244. 244.
    Shvidel L, Shtalrid M, Bassous L, Klepfish A, Vorst E, Berrebi A (1999) B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma 33:169–179PubMedPubMedCentralCrossRefGoogle Scholar
  245. 245.
    Soldini D, Valera A, Sole C, Palomero J, Amador V, Martin-Subero JI, Ribera-Cortada I, Royo C, Salaverria I, Bea S, Gonzalvo E, Johannesson H, Herrera M, Colomo L, Martinez A, Campo E (2014) Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Am J Surg Pathol 38:86–93CrossRefPubMedGoogle Scholar
  246. 246.
    Sole F, Woessner S, Espinet B, Lloveras E, Florensa L, Perez-Losada A, Vila RM, Besses C, Sans-Sabrafen J (1998) Cytogenetic abnormalities in three patients with B-cell prolymphocytic leukemia. Cancer Genet Cytogenet 103:43–45PubMedPubMedCentralCrossRefGoogle Scholar
  247. 247.
    Spencer J, Finn T, Isaacson PG (1985) Gut associated lymphoid tissue: a morphological and immunocytochemical study of the human appendix. Gut 26:672–679PubMedPubMedCentralCrossRefGoogle Scholar
  248. 248.
    Spencer J, Finn T, Isaacson PG (1986) Human Peyer’s patches: an immunohistochemical study. Gut 27:405–410PubMedPubMedCentralCrossRefGoogle Scholar
  249. 249.
    Spencer J, Finn T, Pulford KA, Mason DY, Isaacson PG (1985) The human gut contains a novel population of B lymphocytes which resemble marginal zone cells. Clin Exp Immunol 62:607–612PubMedPubMedCentralGoogle Scholar
  250. 250.
    Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni M, Tabbo F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B, Inghirami G, Bertoni F, Foa R, Rabadan R, Gaidano G, Rossi D (2016) The genetics of nodal marginal zone lymphoma. Blood 128:1362–1373PubMedPubMedCentralCrossRefGoogle Scholar
  251. 251.
    Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, Muller-Hermelink HK (2002) Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 99:3–9PubMedPubMedCentralCrossRefGoogle Scholar
  252. 252.
    Stilgenbauer S, Winkler D, Ott G, Schaffner C, Leupolt E, Bentz M, Moller P, Muller-Hermelink HK, James MR, Lichter P, Dohner H (1999) Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 94:3262–3264PubMedPubMedCentralGoogle Scholar
  253. 253.
    Stolte M, Bayerdorffer E, Morgner A, Alpen B, Wundisch T, Thiede C, Neubauer A (2002) Helicobacter and gastric MALT lymphoma. Gut 50(Suppl 3):III19–III24PubMedPubMedCentralGoogle Scholar
  254. 254.
    Streubel B, Lamprecht A, Dierlamm J, Cerroni L, Stolte M, Ott G, Raderer M, Chott A (2003) T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101:2335–2339PubMedPubMedCentralCrossRefGoogle Scholar
  255. 255.
    Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R, Stolte M, Trautinger F, Lukas J, Puspok A, Formanek M, Assanasen T, Muller-Hermelink HK, Cerroni L, Raderer M, Chott A (2004) Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18:1722–1726PubMedPubMedCentralCrossRefGoogle Scholar
  256. 256.
    Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A (2005) T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 19:652–658PubMedPubMedCentralCrossRefGoogle Scholar
  257. 257.
    Sutton LA, Rosenquist R (2015) Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution. Haematologica 100:7–16PubMedPubMedCentralCrossRefGoogle Scholar
  258. 258.
    Swerdlow SH (2004) Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia. Am J Clin Pathol 122(Suppl):S98–S109PubMedPubMedCentralGoogle Scholar
  259. 259.
    Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375–2390PubMedPubMedCentralCrossRefGoogle Scholar
  260. 260.
    Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E (2016) The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch 468:259–275PubMedPubMedCentralCrossRefGoogle Scholar
  261. 261.
    Swerdlow SH, Cook JR, Sohani AR, Pileri SA, Harris NL et al. (2017) Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: Lyon, S 232–235Google Scholar
  262. 262.
    Swerdlow SH, Campo E, Seto M, Müller-Hermelink HK (2017) Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (Hrsg) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: Lyon, S 285–290Google Scholar
  263. 263.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al (2017) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) IARC: LyonGoogle Scholar
  264. 264.
    Swords R, Bruzzi J, Giles F (2007) Recent advances in the diagnosis and therapy of Richter’s syndrome. Med Oncol 24:17–32PubMedPubMedCentralCrossRefGoogle Scholar
  265. 265.
    Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES (2003) Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 27:522–531CrossRefPubMedGoogle Scholar
  266. 266.
    Takata K, Sato Y, Nakamura N, Kikuti YY, Ichimura K, Tanaka T, Morito T, Tamura M, Oka T, Kondo E, Okada H, Tari A, Yoshino T (2009) Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol 22:940–949CrossRefPubMedGoogle Scholar
  267. 267.
    The Non-Hodgkin’s Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 89:3909–3918Google Scholar
  268. 268.
    Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, Salles G, Coiffier B (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95:802–806PubMedGoogle Scholar
  269. 269.
    Thiede C, Wundisch T, Alpen B, Neubauer B, Morgner A, Schmitz M, Ehninger G, Stolte M, Bayerdorffer E, Neubauer A (2001) Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 19:1600–1609PubMedPubMedCentralCrossRefGoogle Scholar
  270. 270.
    Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S, Pedrinis E, Feller AC, Merz H, Janssen D, Hansmann ML, Krieken H, Moller P, Stein H, Unterhalt M, Hiddemann W, Parwaresch R (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131:29–38PubMedPubMedCentralCrossRefGoogle Scholar
  271. 271.
    Tierens A, Delabie J, Michiels L, Vandenberghe P, De Wolf-Peeters C (1999) Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 93:226–234PubMedGoogle Scholar
  272. 272.
    Tierens A, Delabie J, Pittaluga S, Driessen A, Wolf-Peeters C (1998) Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 91:2381–2386PubMedPubMedCentralGoogle Scholar
  273. 273.
    Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84:1043–1049PubMedPubMedCentralGoogle Scholar
  274. 274.
    Traverse-Glehen A, Bertoni F, Thieblemont C, Zucca E, Coiffier B, Berger F, Salles G (2012) Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma. Oncology 26:92–94PubMedGoogle Scholar
  275. 275.
    Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA, Thieblemont C, Coiffier B, Salles G, Berger F (2006) A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology 48:162–173CrossRefPubMedGoogle Scholar
  276. 276.
    Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR (2012) MYD88 L265P somatic mutation in Waldenstrom’s macroglobulinemia. N Engl J Med 367:826–833CrossRefPubMedPubMedCentralGoogle Scholar
  277. 277.
    van der Velden V, Hoogeveen PG (2014) Blood 124:412–419CrossRefPubMedGoogle Scholar
  278. 278.
    Vegliante MC, Palomero J, Perez-Galan P, Roue G, Castellano G, Navarro A, Clot G, Moros A, Suarez-Cisneros H, Bea S, Hernandez L, Enjuanes A, Jares P, Villamor N, Colomer D, Martin-Subero JI, Campo E, Amador V (2013) SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood 121:2175–2185CrossRefPubMedGoogle Scholar
  279. 279.
    von Duhren MM, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M, Hofmann D, Surova E, Follo M, Kohler F, Wardemann H, Zirlik K, Veelken H, Jumaa H (2012) Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489:309–312CrossRefGoogle Scholar
  280. 280.
    Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K, Werner L, Sivachenko A, DeLuca DS, Zhang L, Zhang W, Vartanov AR, Fernandes SM, Goldstein NR, Folco EG, Cibulskis K, Tesar B, Sievers QL, Shefler E, Gabriel S, Hacohen N, Reed R, Meyerson M, Golub TR, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365:2497–2506PubMedPubMedCentralCrossRefGoogle Scholar
  281. 281.
    Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP (2005) Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 29:1490–1496CrossRefPubMedGoogle Scholar
  282. 282.
    Wartenberg M, Vasil P (2013) Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse. zum Bueschenfelde CM, Ott G, Rosenwald A, Fend F, Kremer M, Bd. 98, S 1433–1441Google Scholar
  283. 283.
    Weir EG, Epstein JI (2003) Incidental small lymphocytic lymphoma/chronic lymphocytic leukemia in pelvic lymph nodes excised at radical prostatectomy. Arch Pathol Lab Med 127:567–572PubMedGoogle Scholar
  284. 284.
    Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma – an entity comes of age. Blood 87:4483–4494PubMedGoogle Scholar
  285. 285.
    Willemze R, Swerdlow SH, Harris NL, Vergier B (2008) Primary cutaneous follicle centre lymphoma. In: Swerdlow SH, Campo E, Jaffe ES, Harris NL, Pileri SA, al (Hrsg) WHO Classification of Tumours of Haematopoetic and Lymphoid Tissues. IARC Press, Lyon, France, S 227–228Google Scholar
  286. 286.
    Williams ME, Whitefield M, Swerdlow SH (1997) Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia. Ann Oncol 8 Suppl 2: 71–73CrossRefGoogle Scholar
  287. 287.
    Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, bdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer MJ (1999) Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell, Bd. 96, S 35–45Google Scholar
  288. 288.
    Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, De BM, Isaacson PG (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577CrossRefPubMedGoogle Scholar
  289. 289.
    Wotherspoon AC, Finn TM, Isaacson PG (1995) Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 85:2000–2004PubMedGoogle Scholar
  290. 290.
    Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176CrossRefPubMedGoogle Scholar
  291. 291.
    Woyach JA, Johnson AJ, Byrd JC (2012) The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood 120:1175–1184PubMedPubMedCentralCrossRefGoogle Scholar
  292. 292.
    Xerri L, Dirnhofer S, Quintanilla-Martinez L, Sander B, Chan JK, Campo E, Swerdlow SH, Ott G (2016) The heterogeneity of follicular lymphomas: from early development to transformation. Virchows Arch 468:127–139CrossRefPubMedGoogle Scholar
  293. 293.
    Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, Morra E, Trojani A, Greco A, Arcaini L, Varettoni M, Brown JR, Tai YT, Anderson KC, Munshi NC, Patterson CJ, Manning RJ, Tripsas CK, Lindeman NI, Treon SP (2013) MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 121:2051–2058PubMedPubMedCentralCrossRefGoogle Scholar
  294. 294.
    Zainuddin N, Murray F, Kanduri M, Gunnarsson R, Smedby KE, Enblad G, Jurlander J, Juliusson G, Rosenquist R (2011) TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia. Leuk Res 35:272–274CrossRefPubMedGoogle Scholar
  295. 295.
    Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 10:37–50CrossRefPubMedGoogle Scholar
  296. 296.
    Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet, Bd. 22, S 63–68Google Scholar
  297. 297.
    Zhang S, Kipps TJ (2014) The pathogenesis of chronic lymphocytic leukemia. Annu Rev Pathol 9:103–118PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für Klinische PathologieRobert-Bosch-KrankenhausStuttgartDeutschland

Personalised recommendations